摘要
目的 建立超高效液相色谱-质谱联用技术(UPLC-MS)测定大鼠血浆中甘油三油酸酯含量的方法,研究薏苡仁油纳米粒给药系统大鼠体内药物动力学和口服生物利用度。方法 将随机分组的大鼠分别灌胃给药薏苡仁油原料、普通口服制剂康莱特软胶囊(市售薏苡仁油普通软胶囊)以及薏苡仁油纳米粒,分别于0.083、0.167、0.25、0.5、0.75、1、2、4、6、8、12、24、36、48、72、96、120 h取血,采用超高效液相色谱-质谱联用技术法测定大鼠血浆样品中甘油三油酸酯的浓度,计算药动学参数。结果 比较薏苡仁油原料、普通口服制剂康莱特软胶囊、薏苡仁油纳米粒的药动学参数,大鼠血浆甘油三油酸酯的ρmax分别为(5.43±0.45)、(7.54±0.44)和(7.30±1.13) mg·L-1,薏苡仁油纳米粒与薏苡仁油原料相比,甘油三油酸酯的ρmax存在显著性差异(P<0.05),薏苡仁油纳米粒与普通薏苡仁油软胶囊相比,甘油三油酸酯的ρmax无显著性差异(P>0.05);大鼠血浆甘油三油酸酯的AUC0-∞分别为(68.71±5.12)、(46.61±3.86)、(178.91±6.26)mg·h·L-1,薏苡仁油纳米粒的AUC0-∞明显高于薏苡仁油原料药及薏苡仁油普通口服制剂;以薏苡仁油原料为参比,薏苡仁油纳米粒中甘油三油酸酯的相对生物利用度为260.38%;以薏苡仁油普通口服制剂为参比,薏苡仁油纳米粒中甘油三油酸酯的相对生物利用度为383.84%。结论 薏苡仁油制成薏苡仁纳米粒给药系统能提高其口服生物利用度并改善其药剂学性质。
Abstract
OBJECTIVE To delevop a UPLC-MS method for determining the content of olein in rat plasma, and investigate the pharmacokinetics and bioavailability of nanoparticles of coix seed oil in rats. METHODS The rats were divided into three groups randomly. They were administered orally suspension of the raw material of the coix seed oil, Kang lai te soft capsules and nanoparticles of coix seed oil, respectively. Blood samples were collected at 0.083, 0.167, 0.25, 0.5, 0.75, 1, 2, 4, 6, 8, 12, 24, 36, 48, 72, 96, and 120 h and the concentrations of olein in rat plasma were determined by UPLC-MS. The pharmacokinetic parameters were calculated by 3P97 pharmacokinetic program. RESULTS The pharmacokinetic parameters of olein in the the raw material of coix seed oil, KLT soft capsules and nanoparticles of coix seed oil in rat plasma were as follows: ρmax were (5.43±0.45), (7.54±0.44) and (7.30±1.13) mg·L-1, respectively, with significant difference between the nanoparticles and raw material (P<0.05), while no significant difference between nanoparticles and common oral prepatation(P>0.05); AUC0-∞ were (68.71±5.12), (46.61±3.86), and (178.91±6.26) mg·h·L-1, respectively, which was the highest for the nanoparticles. The relative bioavailability of olein in the nanoparticles of coix seed oil was 260.38% to the raw material and 383.84% to the common oral prepatation. CONCLUSION The nanoparticles system can increase the bioavailability of coix seed oil and improve its biopharmaceutical property.
关键词
薏苡仁油 /
纳米粒 /
超高效液相色谱-质谱联用 /
药动学 /
相对生物利用度
{{custom_keyword}} /
Key words
coix seed oil /
nanoparticle /
UPLC-MS /
pharmacokinetics /
bioavailability
{{custom_keyword}} /
黄庆德,郑利,陈丹,林伊莉,曾华平.
薏苡仁油纳米粒大鼠体内生物利用度及药动学研究[J]. 中国药学杂志, 2016, 51(1): 40-45 https://doi.org/10.11669/cpj.2016.01.010
HUANG Qing-de, ZHENG Li, CHEN Dan, LIN Yi-li, ZENG Hua-ping.
Bioavailability and Pharmacokinetics of Nanoparticles of Coix Seed Oil[J]. Chinese Pharmaceutical Journal, 2016, 51(1): 40-45 https://doi.org/10.11669/cpj.2016.01.010
中图分类号:
R944
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] ZHENG L,CHEN D,ZHENG L J,et al. Determination of triolein content in Coicis Semen from different regions by UPLC-MS . Chin J Mod Appl Pharm(中国现代应用药学),2014,31(2):200-204.
[2] XIANG Z M,ZHU M,CHEN B L,et al. Identification of triacylglycerols in coix oil by high performance liquid chromatography-atmospheric pressure chemical ionization-mass spectrometry . China J Chin Mater Med(中国中药杂志),2005,30(18):1436-1438.
[3] YU F, GAO J, ZENG Y.Inhibition of Coix seed extract on fatty acid synthase,a novel target for anticancer activity.J Ethnopharmacol,2008,119(2):252-258.
[4] LEE M Y, LIN H Y, CHENG F W,et al.Isolation and characterization of new lactam compounds that inhibit lung and colon cancer cells from adlay (Coix lachryma-jobil.var. ma-yuen Stapf) bran. Food Chem Toxicol,2008,46(6):1933-1939.
[5] KUMARI A,YADAV S K,YADAV S C.Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surfaces B: Biointerfaces,2010,75(1):1-18.
[6] LIU M X, LI H F,LUO G A, et al.Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles. Archibes Pharm Res,2008,31(4):547-554.
[7] PAN P, WU Y, GUO Z Y,et al.Antitumor activity and immunomodulatory effects of the intraperitoneal administration of Kanglaite in vivo in Lewis lung carcinoma. J Ethnopharmacol,2012,143(2):680-685.
[8] LIU X M, XU F, WANG G,et al. Kanglaite Injection plus chemotherapy versus chemotherapy alone for non-small cell lung cancer patients:A systematic reviewand Meta-analysis Kanglaite Injection plus chemotherapy versus chemotherapy alone for non-small cell lung cancer patients:A systematic reviewand Meta-analysis. Curr Therapeu Res,2008,69(5):381-411.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
福建省科技计划重点项目(2014Y0062);福建省科技计划项目(2010Y2004)
{{custom_fund}}